Document is current
Any future updates will be listed below
-
Authors
Clayton, Lisa M. https://orcid.org/0000-0002-1928-8054
Vakrinou, Angeliki https://orcid.org/0000-0003-4363-468X
Balestrini, Simona https://orcid.org/0000-0001-5639-1969
Sisodiya, Sanjay M. https://orcid.org/0000-0002-1511-5893
- License Information
-
More Information
Article History
Accepted: 4 March 2025
First Online: 17 May 2025
Declarations
:
: The authors report the following disclosures outside of the submitted work: LMC reports non-financial support from UCB; SB has received personal fees from Angelini, personal fees from Eisai, personal fees from Jazz Pharma and personal fees from Biocodex; SMS has received grants from Jazz Pharma, other support from GW Pharma/Jazz Pharma, personal fees and other support from Zogenix, personal fees and other support from Eisai, grants and personal fees from UCB, and other support from Stoke Therapeutics; and is a Member of the Scientific Advisory Board to Dravet Syndrome UK.
